{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:59:17Z","timestamp":1791961157629,"version":"4.3.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/ico.0b013e318298ddf8","type":"journal-article","created":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T11:24:17Z","timestamp":1376047457000},"page":"1315-1320","source":"Crossref","is-referenced-by-count":8,"title":["Vitreous and Aqueous Penetration of Orally Administered Trimethoprim-Sulfamethoxazole Combination in Humans"],"prefix":"10.1097","volume":"32","author":[{"given":"Vahid","family":"Feiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Nijm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph D.","family":"Glickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Telander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Polage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Moshirfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210204","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","article-title":"A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group.","volume":"113","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R2-4-20210204","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0002-9394(14)70487-8","article-title":"A, Meredith TA, Aguilar HE, et al.. Aminoglycoside levels in the rabbit vitreous cavity after intravenous administration.","volume":"122","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"R3-4-20210204","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00006982-199515020-00012","article-title":". Vitreous cavity penetration of ceftazidime after intravenous administration.","volume":"15","author":"Aguilar","year":"1995","journal-title":"Retina"},{"key":"R4-4-20210204","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archopht.121.3.345","article-title":"Vitreous and aqueous penetration of orally administered gatifloxacin in humans.","volume":"121","author":"Hariprasad","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R5-4-20210204","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ophtha.2003.09.042","article-title":". Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration.","volume":"111","author":"Fiscella","year":"2004","journal-title":"Ophthalmology"},{"key":"R6-4-20210204","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ajo.2007.10.020","article-title":". Visual outcome and bacterial sensitivity after methicillin-resistant Staphylococcus aureus-associated acute endophthalmitis.","volume":"145","author":"Deramo","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R7-4-20210204","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jcrs.2008.01.016","article-title":". Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005.","volume":"34","author":"Asbell","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"R8-4-20210204","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajo.2006.05.044","article-title":". Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin.","volume":"142","author":"Deramo","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R9-4-20210204","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/AAC.38.10.2231","article-title":"Antimicrobial susceptibility of coagulase-negative staphylococci.","volume":"38","author":"Archer","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-4-20210204","first-page":"63","article-title":"Synergy of trimethoprim-sulfamethoxazole.","volume":"112","author":"Bushby","year":"1975","journal-title":"Can Med Assoc J"},{"key":"R11-4-20210204","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0732-8893(86)90054-4","article-title":"Susceptibility of Haemophilus influenzae to amoxicillinclavulanic acid, erythromycin, cefaclor, and trimethoprimsulfamethoxazole.","volume":"4","author":"Doern","year":"1986","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R12-4-20210204","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.ajo.2008.01.025","article-title":". Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates.","volume":"145","author":"Asbell","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R14-4-20210204","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1592\/phco.25.2.253.56956","article-title":". Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.","volume":"25","author":"Grim","year":"2005","journal-title":"Pharmacotherapy"},{"key":"R15-4-20210204","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jac\/5.6.717","article-title":"Cerebrospinal fluid concentrations of trimethoprim during oral and parenteral treatment.","volume":"5","author":"Svedhem","year":"1979","journal-title":"J Antimicrob Chemother"},{"key":"R16-4-20210204","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/AAC.26.6.811","article-title":". Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges.","volume":"26","author":"Dudley","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-4-20210204","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/bjo.79.5.462","article-title":". Distribution of a putative endothelial barrier antigen in the ocular and orbital tissues of the rat.","volume":"79","author":"Lawrenson","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"R18-4-20210204","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.ophtha.2005.05.025","article-title":". Prospective randomized trial of trimethoprimsulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.","volume":"112","author":"Soheilian","year":"2005","journal-title":"Ophthalmology"},{"key":"R19-4-20210204","first-page":"86","article-title":"Trimethoprim-sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions.","volume":"17","author":"Kielhofner","year":"1990","journal-title":"Tex Heart Inst J"},{"key":"R20-4-20210204","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jpba.2006.09.004","article-title":"Rapid and simultaneous determination of sulfamethoxazole and trimethoprim in human plasma by high-performance liquid chromatography.","volume":"43","author":"Amini","year":"2007","journal-title":"J Pharm Biomed Anal"},{"key":"R21-4-20210204","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jchromb.2007.12.027","article-title":". Simultaneous determination of sulfamethoxazole and trimethoprim in biological fluids for high-throughput analysis: comparison of HPLC with ultraviolet and tandem mass spectrometric detection.","volume":"863","author":"Bedor","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R22-4-20210204","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/AAC.31.2.144","article-title":"Effect of minimal amounts of thymidine on activity of trimethoprim-sulfamethoxazole against Staphylococcus epidermidis.","volume":"31","author":"Jones","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-4-20210204","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1128\/AAC.29.6.1092","article-title":". In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.","volume":"29","author":"Elwell","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-4-20210204","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/JCM.37.1.215-217.1999","article-title":". Determination of trimethoprim-sulfamethoxazole resistance in Streptococcus pneumoniae by using the E test with Mueller-Hinton agar supplemented with sheep or horse blood may be unreliable. The Pneumococcal Study Group.","volume":"37","author":"Lovgren","year":"1999","journal-title":"J Clin Microbiol"},{"key":"R25-4-20210204","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jcp.27.11.897","article-title":"Sensitivity of Streptococcus pyogenes to sulphamethoxazole, trimethoprim, and cotrimoxazole.","volume":"27","author":"Yourassowsky","year":"1974","journal-title":"J Clin Pathol"},{"key":"R26-4-20210204","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/dkn147","article-title":"Trimethoprim and enterococci in urinary tract infections: new perspectives on an old issue.","volume":"62","author":"Wisell","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"suppl","key":"R27-4-20210204","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/infdis\/128.Supplement_3.S508","article-title":". Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.","volume":"128","author":"Bach","year":"1973","journal-title":"J Infect Dis"},{"key":"R28-4-20210204","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/00365548609032299","article-title":"The antimicrobial activities of trimethoprim and sulfonamides.","volume":"18","author":"Burman","year":"1986","journal-title":"Scand J Infect Dis"},{"key":"R29-4-20210204","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1128\/AAC.14.3.384","article-title":"Susceptibility of anaerobic bacteria to sulfamethoxazoletrimethoprim and routine susceptibility testing.","volume":"14","author":"Wust","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"R30-4-20210204","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.anaerobe.2004.02.002","article-title":". Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm.","volume":"10","author":"Oprica","year":"2004","journal-title":"Anaerobe"},{"key":"R31-4-20210204","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00007435-198804000-00011","article-title":"Two-day trimethoprim-sulfamethoxazole treatment of pharyngeal gonorrhea.","volume":"15","author":"Wulf","year":"1988","journal-title":"Sex Transm Dis"},{"key":"R32-4-20210204","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jac\/22.6.873","article-title":"In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.","volume":"22","author":"Yeldandi","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"R33-4-20210204","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00006454-199603000-00015","article-title":"Pharmacokinetics and pharmacodynamics of antibiotics in otitis media.","volume":"15","author":"Craig","year":"1996","journal-title":"Pediatr Infect Dis J"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e318298ddf8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:35:40Z","timestamp":1621884940000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201310000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318298ddf8","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}